Lower Urinary Tract Dysfunction Database
This study is currently recruiting participants.
Verified December 2016 by Thomas Kessler, Balgrist University Hospital
Balgrist University Hospital
Information provided by (Responsible Party):
Thomas Kessler, Balgrist University Hospital
First received: February 9, 2011
Last updated: December 15, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||January 2030|
|Estimated Primary Completion Date:||January 2030 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Leitner L, Guggenbühl-Roy S, Knüpfer SC, Walter M, Schneider MP, Tornic J, Sammer U, Mehnert U, Kessler TM. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned. Eur Urol. 2016 Sep;70(3):522-8. doi: 10.1016/j.eururo.2016.03.052. Epub 2016 Apr 19.